After the National Institute for Standards and Technology (NIST) identified upcoming challenges in the U.S. biopharmaceutical manufacturing landscape (see document here), the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) was ... More
A guest blog post by RoosterBio Travel Award winner, Ian Kinstlinger. Presenting on Open-source Selective Laser Sintering at WBC2016! Since 1980, the international community of biomaterials scientists and engineers has convened ... More
A guest blog post by RoosterBio Travel Award winner, Gisele Calderon. The World Biomaterials Congress (WBC) takes place every four years with an energy rivaling the Olympics. This Congress is ... More
Human Mesenchymal Stem/Stromal Cells (hMSCs), from bone marrow or other tissues, are poised to have the most significant impact on Regenerative Medicine compared to any other single cell type. This ... More
RoosterBio was founded to accelerate the development of the Regenerative Medicine field by utilizing advancements in Manufacturing Sciences. As such, we have long been involved in laying the groundwork for a Technology ... More
Fisher et al published the first attempt at engineering a full-scale adult human femur head from hMSCs. This is the largest reported tissue to have been engineered and took over ... More
Human mesenchymal stem or stromal cells (hMSCs) are an integral part of cell-based therapeutics, with over 400 clinical trials recently completed or in progress using hMSCs. As more research teams ... More
Introduction RoosterBio is introducing a new product for highly efficient bioreactor expansion of human Mesenchymal Stem/Stromal Cells (hMSCs) that we are calling RoosterReplenish™-MSC. This innovative, first-in-class stem cell product is ... More
INTRODUCTION Human mesenchymal stem cells (hMSC) are currently in use in over 400 clinical trials and are critical components of tomorrow’s cell-based products and devices (1, 2, 3). The secretion ... More
INTRODUCTION Human Mesenchymal Stem/Stromal Cells, or hMSC, are key components of future therapeutics, engineered tissues, and medical devices and are currently in use in over 400 clinical trials (1). Bone ... More
